Company / Tangible Book Value per Share
Rapport Therapeutics, Inc. Tangible Book Value per Share History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$14.73
FY2024
5-year range
-$17.02 / $14.73
FY2023-FY2024
Trend
+186.5%
vs FY2023
Sector context
#35 of 209
Health Care
What the data says
Rapport Therapeutics, Inc.'s tangible book value per share of $14.73 is higher than 83% of companies in the Health Care sector (FY2024).
Based on SEC 10-K filings.
14.73 in FY2024. Top quartile in the Health Care sector.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 17% in Health CareTop 17% of 209This company $14.73 Sector average $93.47
▼
-84.2% below sector average
Key checks
Key Insights
- In FY2024, tangible book value per share increased 186.5% year-over-year.
- Ranks #35 out of 209 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 13.36 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $14.73 | +186.5% |
| FY2023 | -$17.02 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026